DBV Technologies (DBVT) Change in Account Payables (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Change in Account Payables of $100000.0 for Q2 2026, down 97.5% year-on-year from $4.0 million in Q2 2025, and up 120.0% on a QoQ basis from -$500000.0 in Q1 2026.
DBV Technologies (DBVT) Change in Account Payables (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Change in Account Payables for 7 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.
- Quarterly Change in Account Payables fell 97.5% year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $483000.0 (down 97.35% YoY) and the FY2025 annual result came in at $15.8 million, up 5702.57% from the prior year.
- Change in Account Payables climbed to $100000.0 in Q2 2026 per DBVT's latest filing, from -$500000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for DBVT reached as high as $10.9 million in Q1 2025 and fell as low as -$4.8 million in Q1 2024.
- A 5-year average of $1.5 million and a median of $731000.0 in 2024 frame the typical range for Change in Account Payables.
- The largest YoY upside for Change in Account Payables was 23668.42% in 2023 against a maximum downside of 786.15% in 2023.
- Year by year, Change in Account Payables stood at -$2.2 million in 2022, then soared by 400.0% to $6.7 million in 2023, then slumped by 79.76% to $1.4 million in 2024, then rose by 10.13% to $1.5 million in 2025, then sank by 93.33% to $100000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $100000.0, -$500000.0, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | -617,000.00 |
| Sep 30, 2025 | -617,000.00 |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Mar 31, 2025 | 10.90 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | -4.81 Mn |
| Mar 31, 2024 | -4.81 Mn |